Caspofungin Acetate Injection, Powder, Lyophilized, For Solution
Product Images NDC 68083-159

6 FDA label images from Gland Pharma Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Caspofungin Acetate (NDC 68083-159). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Caspofungin Spl 50mg Carton Label

Caspofungin Spl 50mg Carton Label
Packaging label for Caspofungin Acetate for Injection 50 mg/Vial, a lyophilized powder for intravenous injection. The label states the vial contains 50 mg caspofungin equivalent to 55.5 mg caspofungin acetate, to be reconstituted with 10.8 mL diluent for a 5 mg/mL concentration. It includes preparation instructions, storage conditions, and lists inactive ingredients. The labeler is Gland Pharma Limited, India.*
FDA Label Image

Caspofungin Spl 50mg Vial Label

Caspofungin Spl 50mg Vial Label
Label for Caspofungin Acetate for Injection, 50 mg per vial. The product is a single-dose vial for intravenous use only. It must be stored refrigerated between 2°C to 8°C. Each vial contains 50 mg caspofungin acetate equivalent to 55.5 mg caspofungin. Manufactured by Gland Pharma Limited, Hyderabad, India. The label includes storage instructions, discard unused portion directive, and space for lot and expiry information.*
FDA Label Image

Caspofungin Spl 70mg Carton Label

Caspofungin Spl 70mg Carton Label
Packaging label for Caspofungin Acetate for Injection 70 mg/Vial, lyophilized powder for intravenous use. The label states the vial contains 70 mg caspofungin, equivalent to 77.7 mg caspofungin acetate, reconstituted with 10.8 mL diluent to 7 mg/mL. It includes preparation instructions, storage conditions (2° to 8°C), inactive ingredients, and cautions against using diluents containing dextrose. Manufactured by Gland Pharma Limited, India.*
FDA Label Image

Caspofungin Spl 70mg Vial Label

Caspofungin Spl 70mg Vial Label
Label for Caspofungin Acetate for Injection 70 mg per vial, lyophilized powder for intravenous use. Single-dose vial, Rx only. The label includes storage instructions (2 to 8°C), reconstitution information to obtain 7 mg/mL, manufacturer Gland Pharma Limited, and barcode data. The label also has an unvarnished area for lot and expiration dates.*
FDA Label Image

Caspofungin Spl Chemical Structure

Caspofungin Spl Chemical Structure
Chemical structure diagram of Caspofungin Acetate, showing its molecular arrangement including rings, side chains, and acetic acid moieties as part of the compound.*
FDA Label Image

Mostaller Formula

Mostaller Formula
The image shows a mathematical formula for calculating Body Surface Area (BSA) in square meters. It displays BSA as the square root of the product of height in centimeters and weight in kilograms divided by 3600.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.